Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 567Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18Aristo Pharma Gmbh

02 6Kern Pharma Sl

03 6Neuraxpharm Spain Sl

04 6Neuraxpharm Sweden Ab

05 6Sandoz Pharmaceuticals Sa

06 12Stada Pharmaceuticals Ag

07 6Stada Sl Laboratory

08 12Teva Gmbh

09 6Teva Pharma Slu

10 18Zentiva Ks

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Remuva

Dosage Form : Extended-Release Tablet

Dosage Strength : 50MG

Packaging :

Approval Date : 21-11-2022

Application Number : 88300

Regulatory Info : Authorized

Registration Country : Spain

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Remuva

Dosage Form : Extended-Release Tablet

Dosage Strength : 200MG

Packaging :

Approval Date : 21-11-2022

Application Number : 88303

Regulatory Info : Authorized

Registration Country : Spain

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Remuva

Dosage Form : Extended-Release Tablet

Dosage Strength : 250MG

Packaging :

Approval Date : 22-11-2022

Application Number : 88304

Regulatory Info : Authorized

Registration Country : Spain

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Remuva

Dosage Form : Extended-Release Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 22-11-2022

Application Number : 88301

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Remuva

Dosage Form : Extended-Release Tablet

Dosage Strength : 25MG

Packaging :

Approval Date : 21-11-2022

Application Number : 88299

Regulatory Info : Authorized

Registration Country : Spain

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Remuva

Dosage Form : Extended-Release Tablet

Dosage Strength : 150MG

Packaging :

Approval Date : 21-11-2022

Application Number : 88302

Regulatory Info : Authorized

Registration Country : Spain

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Tapentadol \"Aristo\"

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 17-03-2023

Application Number : 28106737222

Regulatory Info : Prescription

Registration Country : Denmark

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Tapentadol \"Aristo\"

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 17-03-2023

Application Number : 28106737322

Regulatory Info : Prescription

Registration Country : Denmark

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Tapentadol \"Aristo\"

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 200mg

Packaging :

Approval Date : 17-03-2023

Application Number : 28106737422

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Tapentadol Phosphate

Brand Name : Tapentadol \"Aristo\"

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 250mg

Packaging :

Approval Date : 17-03-2023

Application Number : 28106737522

Regulatory Info : Prescription

Registration Country : Denmark

blank